Newsroom

News
Strengthening of Drug Bioinformatics at the Saarbrücken Site
In the context of the tenure negotiations for Drug Bioinformatics Professor Olga Kalinina, the Klaus Faber Foundation is providing €100,000 to the "bioINFpro" project, thereby enabling her long-term stay at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Saarland University. Since 2018, Prof Kalinina, as a Klaus Faber Foundation Professor, has been involved in bioinformatic research on new drugs against infectious diseases. The confirmation of project funding took place on November 6, 2023, on the campus of Saarland University. HIPS is a site of the Helmholtz Centre for Infection Research in cooperation with Saarland University.
06.11.2023
HIPS
Graphic of Cryo-electron microscope reconstruction of the antigen binding region
News
Neutralising antibodies that target resistant bacteria
Antibiotic-resistant bacteria pose a major challenge to healthcare systems worldwide. Due to numerous resistance mechanisms, infections with the pathogen Pseudomonas aeruginosa are particularly feared. Researchers at the German Center for Infection Research (DZIF), the University Hospital Cologne, the Helmholtz Centre for Infection Research in Braunschweig and the University Medical Center Hamburg-Eppendorf have now discovered antibodies that could lead to a highly potent treatment option of acute and chronic infections with P. aeruginosa. The study was published in the prestigious scientific journal Cell.
02.11.2023
HZI Campus
Crystal structure of LasB in complex with a ligand
News
Pathoblockers to the rescue
Researchers from the Department of Drug Design and Optimisation have developed molecules that can drastically reduce the pathogenic effects of the hospital germ Pseudomonas aeruginosa. In this interview, the authors Dr. Jörg Haupenthal and Dr. Andreas Kany tell us why P. aeruginosa is such a big problem, provide insights into their novel treatment strategy and explain which steps are still necessary before clinical use. Their work was published in the journal ACS Central Science.
30.10.2023
HIPS
Fabian Leendertz
News
Fabian Leendertz receives the Hamburg Science Award 2023 for One Health
The Academy of Sciences in Hamburg awards Prof Fabian Leendertz, Director of the Helmholtz Institute for One Health (HIOH), the Hamburg Science Award 2023 for his fundamental work in the field of zoonotic infectious diseases using the One Health concept. Leendertz's research contributes significantly to a better understanding of the mechanisms of disease development and transmission between humans, animals and the environment. The One Health surveillance studies conducted by the Helmholtz Institute for One Health, a site of the Helmholtz Centre for Infection Research (HZI), in sub-Saharan Africa play a crucial role in the prevention of epidemics and pandemics.
13.10.2023
HIOH
[Translate to English:]
News
On the current situation in Israel
The Alliance of Science Organisations in Germany expresses its deepest condolences for the victims of the terrorist attacks on Israel. In particular, our sympathy is with our friends and colleagues in the Israeli scientific community. Israel has been and will always be a prime partner for the German research and innovation community.
12.10.2023
HZI Campus
New findings on SARS-CoV-2: Jun Prof Mathias Munschauer with PhD student Sabina Ganskih in the lab.
News
A human factor
How SARS-CoV-2 initiates its replication process during infection is not yet fully understood. Researchers from the Helmholtz Institute Würzburg have now shown for the first time in the journal Cell that it is the human protein SND1 which works together with the viral protein NSP9 to stimulate the virus’s genetic replication program in infected cells. The scientists were surprised to find that NSP9 acts as the first building block in the production of new viral genetic material. The findings are significant for further basic research, but they could also lead to new avenues for the treatment of COVID-19 and other infectious diseases caused by coronaviruses.
04.10.2023
HIRI

HZI in the media

Naturstoffforschung: Rolf Müller erhält den „Tu Youyou Award 2024“

University Bloomington (USA). Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung in Zusammenarbeit mit ...

05.05.2025
|
Management & Krankenhaus
BioVaria 2025 zeichnet Citrapeutics und Green Elephant Biotech mit Startup Pitch & Partner Awards aus

ermöglicht. Citrapeutics, ein Spin-off des Helmholtz-Zentrums für Infektionsforschung, entwickelt neuartige Immuntherapien gegen Krebs, die

05.05.2025
|
Bionity.COM
Unerwarteter Bakterienstopper

... des Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI) in Würzburg, einem Standort des Braunschweiger Helmholtz-Zentrums ...

02.05.2025
|
Bionity.COM
Förderung von Forschung und Musik

... und einen Molekularbiologen, der am Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) an der Entwicklung ...

01.05.2025
|
Rotary Magazin
Multi-resistant bacteria: development of new antibiotics

Prof. Rolf Müller is Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and ...

29.04.2025
|
Analytik NEWS
Deep Dive: Über den Brain Drain in der US-Forschung spricht Helmholtz-Geschäftsführer Penninger

... zusammenarbeiten“, sagt Josef Penninger, wissenschaftlicher Geschäftsführer des Helmholtz-Zentrum für Infektionsforschung in ...

25.04.2025
|
T3N